eBook: How a CDMO Can Help Overcome LNP & Liposome Challenges - 9

to collaborate with these domain experts who are
passionate about their molecules. This is a true differentiator
for Ascendia.
We take great pride in serving as a partner with a
strong commitment to customer service and developing
a tailored approach for each client. We have
built our reputation one project at a time. It is why
Ascendia has been anointed a " Partner of Choice " by
many clients.
Looking ahead, what are some industry
issues that pharma companies might face
in the future that Ascendia is uniquely
qualified to handle?
The demand for novel bioavailability and solubility enhancement
methods has grown significantly and will
continue to do so. Ascendia caters to this increasing
demand by formulating to the specific molecule, rather
than taking a one-size-fits-all approach.
We are a specialty one-stop-shop CDMO that offers
tailored formulation solutions to ensure a rapid, successful
transition of compounds from preclinical to
the clinic. We are a formulation partner that understands
rational design of dosage forms based on compound
properties, possesses different technologies to
address varied compound challenges, and offers flexibility
in terms of time and deliverables.
Additionally, time to market will continue to be a driving
factor. Ascendia routinely simultaneously utilizes
its three nanotechnologies for insoluble compounds
for formulation screening and in vitro assessment.
The result is faster formulation development to meet
tight timeframes and budget parameters.
9

eBook: How a CDMO Can Help Overcome LNP & Liposome Challenges

Table of Contents for the Digital Edition of eBook: How a CDMO Can Help Overcome LNP & Liposome Challenges